"metastatic tumor" trang 4 - tải miễn phí từ tailieuXANH
Filtration based assessment of CTCs and CellSearch® based assessment are both powerful predictors of prognosis for metastatic breast cancer patients

Filtration based assessment of CTCs and CellSearch® based assessment are both powerful predictors of prognosis for metastatic breast cancer patients
8    96    0
Evolutionary aspects of non-metastatic breast cancer after primary treatment in a sub-Saharan African setting: A 16-year retrospective review at the Douala general hospital, Cameroon

Evolutionary aspects of non-metastatic breast cancer after primary treatment in a sub-Saharan African setting: A 16-year retrospective review at the Douala general hospital, Cameroon
9    66    0
The PANDA study: A randomized phase II study of first-line FOLFOX plus panitumumab versus 5FU plus panitumumab in RAS and BRAF wild-type elderly metastatic colorectal cancer patients

The PANDA study: A randomized phase II study of first-line FOLFOX plus panitumumab versus 5FU plus panitumumab in RAS and BRAF wild-type elderly metastatic colorectal cancer patients
11    63    0
Autoimmune comorbidities in patients with metastatic melanoma: A retrospective analysis of us claims data

Autoimmune comorbidities in patients with metastatic melanoma: A retrospective analysis of us claims data
9    66    0
Unmasking of intracranial metastatic melanoma during ipilimumab/nivolumab therapy: Case report and literature review

Unmasking of intracranial metastatic melanoma during ipilimumab/nivolumab therapy: Case report and literature review
5    71    0
Induction therapy with paclitaxel and bevacizumab followed by switch maintenance therapy with eribulin in Japanese patients with HER2-negative metastatic breast cancer: A multicenter, collaborative, open-label, phase II clinical study for the SBCCSG 35 investigators

Induction therapy with paclitaxel and bevacizumab followed by switch maintenance therapy with eribulin in Japanese patients with HER2-negative metastatic breast cancer: A multicenter, collaborative, open-label, phase II clinical study for the SBCCSG 35 investigators
11    84    0
Phase II trial of eribulin mesylate as a firstor second-line treatment for locally advanced or metastatic breast cancer: A multicenter, single-arm trial

Phase II trial of eribulin mesylate as a firstor second-line treatment for locally advanced or metastatic breast cancer: A multicenter, single-arm trial
7    92    0
Efficacy and safety of weekly nab-paclitaxel plus gemcitabine in Chinese patients with metastatic adenocarcinoma of the pancreas: A phase II study

Efficacy and safety of weekly nab-paclitaxel plus gemcitabine in Chinese patients with metastatic adenocarcinoma of the pancreas: A phase II study
7    103    0
FOLFOX activity in a rare case of metastatic colonic adenocarcinoma of the tongue: A case report

FOLFOX activity in a rare case of metastatic colonic adenocarcinoma of the tongue: A case report
3    90    0
High-precision radiotherapy of motor deficits due to metastatic spinal cord compression (PRE-MODE): A multicenter phase 2 study

High-precision radiotherapy of motor deficits due to metastatic spinal cord compression (PRE-MODE): A multicenter phase 2 study
6    89    0
Efficacy and safety of eribulin in patients with locally advanced or metastatic breast cancer not meeting trial eligibility criteria: A retrospective study

Efficacy and safety of eribulin in patients with locally advanced or metastatic breast cancer not meeting trial eligibility criteria: A retrospective study
7    81    0
Analysis of B7-H4 expression in metastatic pleural adenocarcinoma and therapeutic potential of its antagonists

Analysis of B7-H4 expression in metastatic pleural adenocarcinoma and therapeutic potential of its antagonists
6    79    0
Association between gene expression profile of the primary tumor and chemotherapy response of metastatic breast cancer

Association between gene expression profile of the primary tumor and chemotherapy response of metastatic breast cancer
8    77    0
Panitumumab use in metastatic colorectal cancer and patterns of RAS testing: Results from a Europe-wide physician survey and medical records review

Panitumumab use in metastatic colorectal cancer and patterns of RAS testing: Results from a Europe-wide physician survey and medical records review
9    97    0
Pyrotinib with trastuzumab and aromatase inhibitors as first-line treatment for HER2 positive and hormone receptor positive metastatic or locally advanced breast cancer: Study protocol of a randomized controlled trial

Pyrotinib with trastuzumab and aromatase inhibitors as first-line treatment for HER2 positive and hormone receptor positive metastatic or locally advanced breast cancer: Study protocol of a randomized controlled trial
6    111    1
Treatment patterns and health outcomes in metastatic renal cell carcinoma patients treated with targeted systemic therapies in the UK

Treatment patterns and health outcomes in metastatic renal cell carcinoma patients treated with targeted systemic therapies in the UK
9    113    0
AtezoTRIBE: A randomised phase II study of FOLFOXIRI plus bevacizumab alone or in combination with atezolizumab as initial therapy for patients with unresectable metastatic colorectal cancer

AtezoTRIBE: A randomised phase II study of FOLFOXIRI plus bevacizumab alone or in combination with atezolizumab as initial therapy for patients with unresectable metastatic colorectal cancer
9    103    0
A randomized phase II study of paclitaxel alone versus paclitaxel plus sorafenib in second- and third-line treatment of patients with HER2-negative metastatic breast cancer (PASO)

A randomized phase II study of paclitaxel alone versus paclitaxel plus sorafenib in second- and third-line treatment of patients with HER2-negative metastatic breast cancer (PASO)
9    100    0
Randomized study comparing full dose monotherapy (S-1 followed by irinotecan) and reduced dose combination therapy (S-1/oxaliplatin followed by S-1/irinotecan) as initial therapy for older patients with metastatic colorectal cancer: NORDIC 9

Randomized study comparing full dose monotherapy (S-1 followed by irinotecan) and reduced dose combination therapy (S-1/oxaliplatin followed by S-1/irinotecan) as initial therapy for older patients with metastatic colorectal cancer: NORDIC 9
7    113    0
Treatment patterns and real world clinical outcomes in ER+/HER2- post-menopausal metastatic breast cancer patients in the United States

Treatment patterns and real world clinical outcomes in ER+/HER2- post-menopausal metastatic breast cancer patients in the United States
12    88    0
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.